ASPIRIN IS THE CORNERSTONE OF CARDIOVASCULAR HEALTH

91% of patients with
cardiovascular disease
adhere to an aspirin regimen
when instructed to
by their doctor1

Hand/heart icon
Help save lives with aspirin
View MI* and ischemic stroke risk reduction data
Product and Rx vials icon
Aspirin is still first-line for secondary CV prevention2-4
Learn more about CV practice guideline recommendations
*Nonfatal MI.
References: 1. Gu Q, Dillon CF, Eberhardt MS, Wright JD, Burt VL. Preventive aspirin and other antiplatelet medication use among U.S. adults aged ≥40 years: data from the National Health and Nutrition Examination Survey, 2011-2012. Public Health Rep. 2015;130(6):643-654. 2. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160-2236. 3. Lansberg MG, O'Donnell MJ, Khatri P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(suppl 2):e601S-e636S. 4. Smith SC Jr, Benjamin EJ, Bonow RO, et al; World Heart Federation and the Preventive Cardiovascular Nurses Association. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation. 2011;124(22):2458-2473.